CinCor Pharma, Inc.
CINC · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|
| Market Cap | $566,706 | $375,899 | $375,899 |
| - Cash | $136,606 | $26,078 | $11,484 |
| + Debt | $0 | $0 | $0 |
| Enterprise Value | $430,100 | $349,821 | $364,414 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$34,630 | -$19,916 | -$5,137 |
| % Margin | – | – | – |
| Net Income | -$50,347 | -$22,262 | -$4,933 |
| % Margin | – | – | – |
| EPS Diluted | -1.42 | -0.95 | -0.21 |
| % Growth | -49.5% | -352.4% | – |
| Operating Cash Flow | -$30,847 | -$17,396 | -$4,430 |
| Capital Expenditures | $0 | $0 | $0 |
| Free Cash Flow | -$30,847 | -$17,396 | -$4,430 |